hyaluronic acid-Gd (Hyal)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehyaluronic acid-Gd (Hyal)
Drug Alias Namehyaluronic acid-Gd (SkyePharma)hyaluronic acid-gadolinium (SkyePharma)HA -Gd (SkyePharma)hyaluronic acid-gadolinium
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPacira Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacira Biosciences Inc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A